Table 1.
Compounds | Target Domain or Process | Mechanism | Reference |
---|---|---|---|
PJ34, N-(6-oxo-5,6-dihydrophenanthridin-2-yl) (N,N-dimethylamino) acetamide hydrochloride | NTD | Reduce RNA binding | [14,67] |
H3, 6-chloro-7-(2-morpholin-4-ylethylamino) quinoxaline-5,8-dione | NTD | Reduce RNA binding | [61] |
(−)-catechin gallate | NTD | Reduce RNA binding | [66] |
(−)-gallocatechin gallate | NTD | Reduce RNA binding | [66] |
P3, 5-benzyloxygr- amine | CTD | Induce abnormal dimerization | [62] |
1,6-hexanediol | LLPS | prevent condensate formation | [68] |
Lipoic acid | LLPS | Reduce smaller condensate | [68,69] |